A practical asset enabling fast-to-market products

We are establishing commercial manufacturing facilities in Emeryville, CA to build upon our existing clinical cGMP manufacturing capabilities in Berkeley, CA. Internalizing core infrastructure including cGMP manufacturing at commercial scale enables Agenus and our subsidiaries to reduce manufacturing timelines and costs, improve quality of manufacturing, de-risk development, and improve flexibility to advance our portfolio of pipeline programs.

Berkeley, CA

Clinical cGMP manufacturing facility

  • 25,000 sq. foot clinical cGMP facility acquired from XOMA Inc. in 2015
  • Team of 70 scientists, engineers, technologists who have developed >20 antibody candidates

Emeryville, CA

Fully integrated commercial cGMP manufacturing facility for biologics

  • ~83,000 sq. foot commercial cGMP facility construction completed
  • Designed for fully integrated biologics cGMP and commercial production to reduce reliance on third-party services, including:
    • Drug substance manufacturing
    • Drug product fill/finish
    • Visual inspection
    • Packaging & labeling
    • Distribution
    • Warehousing (shipping/receiving)
  • Reduces manufacturing timelines and costs while improving flexibility

Vacaville, CA

Commercial manufacturing expansion across therapeutic modalities

  • 80 acre greenfield site, with plans to house a ~500,000 sq. foot facility
  • Designed for commercial manufacturing expansion for internal pipeline of biologics, cell therapy, adjuvants and beyond with support development laboratories for product life cycle management